Abstract:Infantile hemangioma (IH), the most common tumor of infancy, is characterized by an initial proliferation during infancy followed by spontaneous involution over the next 5-10 years, often leaving a fibro-fatty residuum. IH is traditionally considered a tumor of the microvasculature. However, recent data show the critical role of stem cells in the biology of IH with emerging evidence suggesting an embryonic developmental anomaly due to aberrant proliferation and differentiation of a hemogenic endothelium with a neural crest phenotype that possesses the capacity for endothelial, hematopoietic, mesenchymal, and neuronal differentiation. Current evidence suggests a putative placental chorionic mesenchymal core cell embolic origin of IH during the first trimester. This review outlines the emerging role of stem cells and their interplay with the cytokine niche that promotes a post-natal environment conducive for vasculogenesis involving VEGFR-2 and its ligand VEGF-A and the IGF-2 ligand in promoting cellular proliferation, and the TRAIL-OPG anti-apoptotic pathway in preventing cellular apoptosis in IH. The discovery of the role of the renin-angiotensin system in the biology of IH provides a plausible explanation for the programed biologic behavior and the β-blocker-induced accelerated involution of this enigmatic condition. This crucially involves the vasoactive peptide, angiotensin II, that promotes cellular proliferation in IH predominantly via its action on the ATIIR2 isoform. The role of the RAS in the biology of IH is further supported by the effect of captopril, an ACE inhibitor, in inducing accelerated involution of IH. The discovery of the critical role of RAS in IH represents a novel and fascinating paradigm shift in the understanding of human development, IH, and other tumors in general.

A large purplish swelling on the arm of a newborn

Infantile hemangioma-like vascular lesion in a 26-year-old woman after abortion.

Infantile haemangioma: Part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities

[Non-Involuting Congenital Hemangioma: a Study for Diagnosis and Treatment].

Cutaneous Congenital Defects

Rapidly Involuting Congenital Hemangioma with Fetal Involution

Giant congenital fibroblastic connective tissue nevus associated with vascular anomalies

P28 Congenital Cellular Plexiform Schwannoma Masquerading as Infantile Haemangioma – A Case Report

O10 Multifocal congenital haemangiomas: expanding our understanding of “neonatal haemangiomatosis” – case series

[Imaging Diagnosis of Hemangioma in Infants].

A 9-year-old Girl with Fibrous Hamartoma of Infancy

Case report: Infant with a Fast-growing Soft Tissue Tumor on the Thumb, Revealing a PLAG1-positive Connatal Lipoblastoma

Firm Digital Papulonodules in an Infant.

An Infant with High-Output Heart Failure and Pulmonary Hypertension Resulting from a Giant Cutaneous Hemangioma

A Rare Atypical Rapidly Involuting Congenital Hemangioma Combined with Vascular Malformation in the Upper Limb.

Hemangioma of the Tongue: A Case Report

A Case of Complex Hemangioendothelioma of the Liver in an Infant.

A case of Kaposiform hemangioendothelioma

Diagnostic and Therapeutic Challenges of a Large Tongue Lymphangioma in a Child: A Case Report

Forehead lipoblastoma mimicking a hemangioma

Biology of Infantile Hemangioma